Fresh frozen plasma (FFP)
Brand names: Octaplas (solvent-detergent)
Fresh frozen plasma (FFP) is a blood component containing clotting factors, used to replace coagulation factors in bleeding or before procedures in patients with significant coagulopathy.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It supplies the full range of plasma coagulation factors and proteins, supporting clot formation where multiple factors are deficient.
Prescribing in practice
- FFP should only be transfused for clinically significant coagulopathy with bleeding or before invasive procedures, not to correct minor abnormalities or as a volume expander.
- ABO compatibility is required and transfusion reactions, including transfusion-related acute lung injury, can occur.
- It must be given with correct patient identification and observation as for any blood component.
Monitoring
Monitor coagulation results and clinical bleeding to assess response, and observe closely for transfusion reactions during and after administration.
Counselling the patient
- You will be observed during the transfusion for any reaction.
- Report fever, breathlessness, rash or feeling unwell during the infusion.
- The team will explain why a plasma transfusion is needed in your case.
Evidence & guidelines
Restricting FFP to clinically significant coagulopathy reflects NICE blood transfusion guidance and national transfusion recommendations.
Reference: NHSBT major-haemorrhage protocol; BSH guidelines; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Mean Arterial Pressure (MAP) · Haemodynamics
- Duke Criteria for Infective Endocarditis · Diagnosis
- 2023 Duke-ISCVID Criteria for Infective Endocarditis · Infective Endocarditis
- Estimated Blood Alcohol Concentration · Toxicology
- Hypoglycaemia Severity Classification · Diabetes Management
- PLASMIC Score for TTP · Haematological Diagnosis
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Anaemia Investigation · BSH / NICE
- Splenomegaly Workup · BSH; BMJ Best Practice
- Deep Vein Thrombosis Diagnosis and Treatment · NICE CG144 / NICE NG158
- Sickle Cell Crisis · BSH 2021 / BCSH
- Neutropenic Sepsis · NICE CG151 2012 / ESMO